New Leadership Options for Research Institute of the MUHC Being Explored

Research Institute of the MUHC Focused on COVID-19 Priorities

Montreal, — The Board of Directors of the Research Institute of the McGill University Health Centre (RI-MUHC) acknowledged today Dr. Constantine Stratakis’ decision to withdraw from his RI-MUHC and associated appointments at the MUHC and McGill University. Dr. Stratakis, who was scheduled to take up his responsibilities on June 1, 2020, confirmed that circumstances beyond his and his family's control forced him to reconsider their future.

The Board will be meeting to discuss the next steps to staff the position of Executive Director and Chief Scientific Officer (ED/CSO). As Interim ED/CSO, Dr. Bruce Mazer will continue to assure the leadership of the RI-MUHC at this time. Given the essential-work-only directives from Government during the COVID19 pandemic, the RI-MUHC is focused predominantly on the numerous clinical trials to understand the coronavirus that are being led by its investigators, as well as on their tireless efforts to develop a vaccine and other related innovations.